ArticleAnnals of hematology2022

Outcome after allogeneic hematopoietic stem cell transplantation following Venetoclax-based therapy among AML and MDS patients.

Ting-Ting Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.